On the use of substandard medicines in hematology: An emerging concern in the Middle East and North Africa region-Reference-Cited by-同舟云学术

On the use of substandard medicines in hematology: An emerging concern in the Middle East and North Africa region

Published:2018-02 Issue: Volume:48 Page:e40-e41
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Mattar Mervat,Alwan Alaa F.,Boukhelal Houria,Chouffai Zoubir,Farhat Fadi,Hadipour Mahmoud,Hamada Emad,Jaffar Mohamed Kadhim,Karimi Mehran,Al-Kasim Fawaz,Al-Momen Hayder H.,Tarawah Ahmad M.,Johnston Atholl,Musallam Khaled M.

Publisher

Elsevier BV

Subject

Internal Medicine

Reference8 articles.

1. Generic oncology drugs: are they all safe?;Yang;Lancet Oncol,2016

2. Substandard drugs: a potential crisis for public health;Johnston;Br J Clin Pharmacol,2013

3. The differences between the branded and generic medicines using solid dosage forms: in-vitro dissolution testing;Al Ameri;Res. Pharma Sci.,2012

4. Cytogenetic response in chronic myeloid leukaemia patients treated with imatinib mesylate homolog-drugs: 6year's transitional study;Khoshnaw;J Cancer Ther,2014

5. Failure of copy Imatib (CIPLA, India) to maintain hematologic and cytogenetic responses in chronic myeloid leukemia in chronic phase;Mattar;Int J Hematol,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal and neonatal outcomes in adolescent pregnant women with one prior Cesarean section in Baghdad;Journal of the Turkish-German Gynecological Association;2023-06-07

2. Green tea influence on iron overload in thalassemia intermedia patients: a randomized controlled trial;F1000Research;2020-09-16